Gene Therapy - Table of Contents alert Volume 18 Issue 12

Special Feature: Non-coding RNAs and the Advent of New Directions in Therapeutics Guest Editor: Joseph C Glorioso, University of Pittsburgh, Pittsburgh, PA, USA TABLE OF CONTENTS Volume 18, Issue 12 (December 2011) In this issue Editorial Reviews Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Scientific Reports – Call for papers Publishing made easy! Entirely open access with papers accepted on technical merit, the community evaluates the importance of papers post-peer review. Scientific Reports exists to facilitate the rapid peer review and publication of research that is of interest to specialists within any given field in the natural sciences. Submit now!   Editorial Top Non-coding RNAs and the advent of new directions in therapeutics J C Glorioso Gene Ther 2011 18: 1103; 10.1038/gt.2011.150 Full Text Reviews Top MicroRNA therapeutics J A Broderick and P D Zamore Gene Ther 2011 18: 1104-1110; advance online publication, April 28, 2011; 10.1038/gt.2011.50 Abstract | Full Text Chemical modification and design of anti-miRNA oligonucleotides K A Lennox and M A Behlke Gene Ther 2011 18: 1111-1120; advance online publication, July 14, 2011; 10.1038/gt.2011.100 Abstract | Full Text Developing therapeutic microRNAs for cancer A G Bader, D Brown, J Stoudemire and P Lammers Gene Ther 2011 18: 1121-1126; advance online publication, June 2, 2011; 10.1038/gt.2011.79 Abstract | Full Text Special delivery: targeted therapy with small RNAs D Peer and J Lieberman Gene Ther 2011 18: 1127-1133; advance online publication, April 14, 2011; 10.1038/gt.2011.56 Abstract | Full Text Current progress in the development of RNAi-based therapeutics for HIV-1 J Zhou and J J Rossi Gene Ther 2011 18: 1134-1138; advance online publication, September 29, 2011; 10.1038/gt.2011.149 Abstract | Full Text Using non-coding small RNAs to develop therapies for Huntington's disease Y Zhang and R M Friedlander Gene Ther 2011 18: 1139-1149; 10.1038/gt.2011.170 Abstract | Full Text Original Articles Top Preclinical development of siRNA therapeutics for AL amyloidosis B M Hovey, J E Ward, P Soo Hoo, C J O'Hara, L H Connors and D C Seldin Gene Ther 2011 18: 1150-1156; advance online publication, May 12, 2011; 10.1038/gt.2011.69 Abstract | Full Text The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models G Cherubini, C Kallin, A Mozetic, K Hammaren-Busch, H Müller, N R Lemoine and G Halldén Gene Ther 2011 18: 1157-1165; advance online publication, October 6, 2011; 10.1038/gt.2011.141 Abstract | Full Text Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle H Karvinen, E Pasanen, T T Rissanen, P Korpisalo, E Vähäkangas, A Jazwa, M Giacca and S Ylä-Herttuala Gene Ther 2011 18: 1166-1172; advance online publication, May 12, 2011; 10.1038/gt.2011.66 Abstract | Full Text Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis L S Pike, B A Tannous, N C Deliolanis, G Hsich, D Morse, C-H Tung, M Sena-Esteves and X O Breakefield Gene Ther 2011 18: 1173-1178; advance online publication, September 8, 2011; 10.1038/gt.2011.118 Abstract | Full Text Corrigendum Top Targeting gene expression to cones with human cone opsin promoters in recombinant AAV A M Komáromy, J J Alexander, A E Cooper, V A Chiodo, G M Acland, W W Hauswirth and G D Aguirre Gene Ther 2011 18: 1179; 10.1038/gt.2011.156 Full Text Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle H Karvinen, E Pasanen, T T Rissanen, P Korpisalo, E Vähäkangas, A Jazwa, M Giacca and S Ylä-Herttuala Gene Ther 2011 18: 1180; advance online publication, June 9, 2011; 10.1038/gt.2011.93 Full Text Advertisement Nature Cell Biology Focus on Cell cycle and DNA damage The maintenance of genomic integrity requires tight control of the cell division process as well as accurate repair of damaged DNA, and failure in such mechanisms can cause developmental disorders and cancer. In the October issue of Nature Cell Biology, leading scientists highlight and discuss new developments in these areas. Access the Focus online for FREE in October: www.nature.com/ncb/webfocus/cellcycle   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.